摘要
<jats:title>Abstract</jats:title><jats:p>Major depressive disorder (MDD) is a prevalent and debilitating psychiatric mood disorder that lacks objective laboratory-based tests to support its diagnosis. A class of microRNAs (miRNAs) has been found to be centrally involved in regulating many molecular processes fundamental to central nervous system function. Among these miRNAs, miRNA-134 (miR-134) has been reported to be related to neurogenesis and synaptic plasticity. In this study, the hypothesis that plasma miR-134 can be used to diagnose MDD was tested. Perturbation of peripheral and central miR-134 in a depressive-like rat model was also examined. By reverse-transcription quantitative PCR, miR-134 was comparatively measured in a small set of plasma samples from MDD and healthy control (HC) subjects. To determine its diagnostic efficacy, plasma miR-134 levels were assessed in 100 MDD, 50 bipolar disorder (BD), 50 schizophrenic (SCZ), and 100 HC subjects. A chronic unpredictable mild stress (CUMS) rat model was also developed to evaluate miR-134 expression in plasma, hippocampus (HIP), prefrontal cortex (PFC), and olfactory bulb. We found that plasma miR-134 was significantly downregulated in MDD subjects. Diagnostically, plasma miR-134 levels could effectively distinguish MDD from HC with 79% sensitivity and 84% specificity, while distinguishing MDD from HC, BD, and SCZ subjects with 79% sensitivity and 76.5% specificity. Congruent with these clinical findings, CUMS significantly reduced miR-134 levels in the rat plasma, HIP, and PFC. Although limited by the relatively small sample size, these results demonstrated that plasma miR-134 displays potential ability as a biomarker for MDD.</jats:p>
- Deciphering the neural mechanisms of miR-134 in major depressive disorder with population-based and person-specific imaging transcriptomic techniquesLou, Jing; Liu, Kai; Wen, Junyan; He, Yini; Sun, Yuqing; Tian, Xiaohan; Hu, Ke; Deng, Yanjia*; Liu, Bing*; Wen, Ge*PSYCHIATRY RESEARCH, 2023, 329: 115551.
- Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networksWu, Zixuan; Cai, Zhixiang; Shi, Hongshuo; Huang, Xuyan; Cai, Minjie; Yuan, Kai; Huang, Peidong; Shi, Guoqi; Yan, Tao; Li, Zhichao*Aging-US, 2022, 14(8): 3569-3596.被引 6
- Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorderDeng, Yanjia; Gong, Ping; Han, Shuguang; Zhang, Jingyu; Zhang, Shuai; Zhang, Bin; Lin, Yong; Xu, Kai; Wen, Ge*; Liu, Kai*PSYCHOLOGICAL MEDICINE, 2023, 53(13): 6253-6260.被引 2
